Skip to content

Effect of Homeopathic LM Potency in Stress-Related Prediabetic Patients

Utility of LM potency in management of stress related Pre-diabetic Cases An experimental uncontrolled clinical study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/108387
Enrollment
44
Registered
2026-04-15
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R739- Hyperglycemia, unspecified

Interventions

Intervention1: Individualized Homeopathic LM Potency Treatment: Individualized homeopathic medicines in LM potency will be prescribed based on symptom totality using repertorization. Medicines will be

Sponsors

Dr Shobha Ramanand Chauhan
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients of either gender (male and female) Patients aged between 20 and 70 years Patients diagnosed with prediabetes based on blood investigations such as HbA1c, fasting blood glucose, or oral glucose tolerance test Patients with stress-related prediabetic condition Patients without microvascular or macrovascular complications Patients willing to participate and provide informed consent Patients available for regular follow-up during the study period

Exclusion criteria

Exclusion criteria: Patients with diagnosed diabetes mellitus with complications Patients with microvascular or macrovascular complications such as retinopathy, nephropathy, neuropathy, or cardiovascular disease Patients with severe systemic or life-threatening illnesses Patients with autoimmune disorders Pregnant or lactating women Patients with HbA1c greater than 11% Patients currently on long-term steroid or immunosuppressive therapy Patients unwilling to participate or unable to comply with follow-up Patients aged below 20 years or above 70 years

Design outcomes

Primary

MeasureTime frame
Change in fasting blood glucose and postprandial blood glucose levels after treatmentTimepoint: Outcomes will be assessed at baseline (Day 0), at 3 months (12 weeks), 6 months (24 weeks), and 12 months (end of treatment).

Secondary

MeasureTime frame
NILTimepoint: NIL

Countries

India

Contacts

Public ContactDr Shobha Ramanand Chauhan

Sonajirao Kshirsagar Homeopathic Medical College

ganagluck@gmail.com9422240256

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026